BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 6175458)

  • 1. Genetic and clinical studies of serum beta 2-microglobulin levels in haematological malignancies.
    Nakao Y; Matsumoto H; Miyazaki T; Watanabe S; Masaoka T; Takatsuki K; Kishihara M; Kobayashi N; Hattori M; Fujita T
    Clin Exp Immunol; 1981 Oct; 46(1):134-41. PubMed ID: 6175458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta 2-microglobulin: a potentially useful marker for hematologic malignancies.
    Garewal H; Durie BG
    Ariz Med; 1981 Dec; 38(12):912-3. PubMed ID: 6174109
    [No Abstract]   [Full Text] [Related]  

  • 3. [Analysis of serum beta 2-microglobulin in multiple myeloma, non-Hodgkin's malignant lymphoma and chronic lymphoid leukemia].
    Balikó Z; Tornóczky J; Pasztarak E; Tóth A; Muth L
    Orv Hetil; 1983 Jan; 124(3):131-4. PubMed ID: 6188088
    [No Abstract]   [Full Text] [Related]  

  • 4. [Beta 2 microglobulin].
    Clément F
    Schweiz Med Wochenschr; 1983 Jun; 113(23):838-43. PubMed ID: 6192496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical studies on serum beta2-microglobulin in multiple myeloma and other related diseases (author's transl)].
    Nishioka F; Yachi A; Wada T
    Rinsho Ketsueki; 1978 Feb; 19(2):100-6. PubMed ID: 77342
    [No Abstract]   [Full Text] [Related]  

  • 6. Serum ferritin and beta 2-microglobulin in patients with multiple myeloma.
    Linkesch W; Ludwig H
    Cancer Detect Prev; 1983; 6(1-2):297-301. PubMed ID: 6192921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta 2-microglobulin in haematological malignancies.
    Br Med J (Clin Res Ed); 1981 Mar; 282(6269):1013. PubMed ID: 6163499
    [No Abstract]   [Full Text] [Related]  

  • 8. [Serum ferritin and beta-2-microglobulin in multiple myeloma].
    Linkesch W; Ludwig H
    Acta Med Austriaca; 1982; 9(5-6):227-31. PubMed ID: 6187172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Serum beta-2-microglobulin in multiple myeloma. Practical value].
    Bataille R; Magub M; Sany J; Donadio D; Izarn P; Grenier J; Suquet P
    Rev Rhum Mal Osteoartic; 1981 Mar; 48(3):235-40. PubMed ID: 6164091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The behaviour of beta-2-microglobulin in acute and chronic leukaemias.
    Schena FP; Liso V; Losuriello V; Mera S; Bonomo L
    Biomedicine; 1980 Feb; 33(1):12-5. PubMed ID: 6154490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgG heavy chain allotype (Gm), a genetic marker for human chromosome 14q32, and haematopoietic malignancies.
    Nakao Y; Matsumoto H; Tsuji K; Miyazaki T; Masaoka T; Nakayama S; Kinoshita K; Shingami T; Matsui T; Fujita T
    Clin Exp Immunol; 1984 Jun; 56(3):628-36. PubMed ID: 6430611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. beta 2-Microglobulin and beta 2-microglobulin-binding proteins in inflammatory diseases.
    Revillard JP; Vincent C; Clot J; Sany J
    Eur J Rheumatol Inflamm; 1982; 5(4):398-405. PubMed ID: 6185339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. beta-2-microglobulin. Quantitation by rocket immunoelectrophoresis and evaluation of serum levels in renal transplant patients.
    Barnes RM; Alexander LC
    Transplantation; 1983 Jun; 35(6):552-5. PubMed ID: 6191415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum ferritin levels in hematologic malignant neoplasms.
    Patel AR; Shah PC; Vohra RM; Hart WL; Shah JR
    Arch Pathol Lab Med; 1980 Oct; 104(10):509-12. PubMed ID: 6932189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical usefulness of serum beta2-microglobulin determination in patients with multiple myeloma].
    Kraj M; Maj S; Pogłód R; Rostkowska J
    Acta Haematol Pol; 1989; 20(2):140-51. PubMed ID: 2700533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Serum levels of beta 2-microglobulin in malignant hemopathies].
    López Fernández A; Cuesta B; Rocha E
    Sangre (Barc); 1985; 30(3):320-9. PubMed ID: 3898421
    [No Abstract]   [Full Text] [Related]  

  • 17. [Value of the determination of beta-2-microglobulin in the monitoring of myeloma. Apropos of 290 determinations].
    Kaltwasser P; Sauger F; Le Loet X; Pasquis P; Monconduit M; Deshayes P
    Rev Rhum Mal Osteoartic; 1982 Apr; 49(5):359-63. PubMed ID: 6179150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Quantitative measurement and clinical analysis of serum levels of immunosuppressive acidic protein (IAP) in hematopoietic malignancies].
    Hamaguchi H; Karitani Y; Minami N; Tanaka I; Iwata Y; Shirakawa S
    Gan To Kagaku Ryoho; 1984 Jun; 11(6):1231-6. PubMed ID: 6732251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radioimmunoassay determinations of murine beta 2-microglobulin and an H-2 antigen-like serum component.
    Kvist S; Peterson PA
    Eur J Immunol; 1979 Dec; 9(12):991-6. PubMed ID: 95109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum beta 2-microglobulin in lymphoproliferative and myeloproliferative diseases.
    Child JA; Kushwaha MR
    Hematol Oncol; 1984; 2(4):391-401. PubMed ID: 6396193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.